EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Intermittent Letermovir Dosing in Cytomegalovirus High‐Risk Liver Transplant Recipients May Facilitate Development of Cell‐Mediated Immunity and Prevent Post‐Prophylaxis Infection

Hanna L Kleiboeker, Chris M Saddler, Margaret R Jorgenson

Transplant Infectious Disease · 2026-07 · 28 (4)

DOI: 10.1111/tid.70244 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Transplant Infectious Disease, online erschienen am 19.05.2026. Verfasst von Hanna L Kleiboeker und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA.
  • Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA.

Zitieren

APA

Kleiboeker, H. L., Saddler, C. M., & Jorgenson, M. R. (2026). Intermittent Letermovir Dosing in Cytomegalovirus High‐Risk Liver Transplant Recipients May Facilitate Development of Cell‐Mediated Immunity and Prevent Post‐Prophylaxis Infection. Transplant Infectious Disease, 28(4). https://doi.org/10.1111/tid.70244

Vancouver

Kleiboeker HL, Saddler CM, Jorgenson MR. Intermittent Letermovir Dosing in Cytomegalovirus High‐Risk Liver Transplant Recipients May Facilitate Development of Cell‐Mediated Immunity and Prevent Post‐Prophylaxis Infection. Transplant Infectious Disease. 2026;28(4). doi:10.1111/tid.70244

BibTeX
@article{Kleiboeker2026,
  author = {Kleiboeker, Hanna L and Saddler, Chris M and Jorgenson, Margaret R},
  title = {Intermittent Letermovir Dosing in Cytomegalovirus High‐Risk Liver Transplant Recipients May Facilitate Development of Cell‐Mediated Immunity and Prevent Post‐Prophylaxis Infection},
  journal = {Transplant Infectious Disease},
  year = {2026},
  volume = {28},
  number = {4},
  doi = {10.1111/tid.70244}
}
Kostenlos starten →